- Adjusted EBITDA increased by 59% year-over-year on an underlying basis to $50.8 million.
- Adjusted net income grew approximately 85% year-over-year on an underlying basis, reaching $36 million.
- Approximately $15 million of common stock was repurchased under the authorized $500 million share repurchase program.
- Free cash flow was robust despite a $19.3 million strategic inventory build to support ASCENIV demand, ending the quarter with $90.3 million in cash.
- GAAP net income was $34.2 million.
- Gross profit rose to $67.2 million with gross margins improving to 55.1%, a 7.7% expansion on an underlying basis.
- Total revenues for Q2 2025 reached $122 million, representing a 14% year-over-year increase or approximately 29% growth on an underlying basis excluding a nonrecurring Medicaid rebate accrual reversal from 2024.
Related items and other data are not available for this feed item.
Dafinchi